Immediate Impact
34 standout
Citing Papers
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities
2024 Standout
Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis
2023 Standout
Works of L. Hargarter being referenced
<p>Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia</p>
2019
Pharmacokinetics and dopamine d2 and serotonin 5-ht2a receptor occupancy of paliperidone in healthy subjects: two open-label, single-dose studies (PAL-115)
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| L. Hargarter | 447 | 37 | 149 | 146 | 33 | 489 | |
| W. Gaebel | 420 | 46 | 171 | 154 | 30 | 527 | |
| Patrick T. Donlon | 388 | 30 | 149 | 94 | 31 | 566 | |
| Fernando Cañas | 301 | 25 | 118 | 68 | 29 | 459 | |
| David M. Engelhardt | 369 | 67 | 171 | 74 | 38 | 554 | |
| G Mignot | 334 | 32 | 107 | 107 | 15 | 412 | |
| F. Cañas | 312 | 22 | 93 | 55 | 25 | 429 | |
| D. Dassa | 331 | 30 | 131 | 71 | 39 | 572 | |
| N. Keyter | 307 | 16 | 146 | 104 | 12 | 440 | |
| Richard M. Steinbook | 330 | 18 | 88 | 83 | 21 | 500 | |
| Jamie Karagianis | 363 | 27 | 125 | 65 | 24 | 487 |
All Works
Login with ORCID to disown or claim papers
Loading papers...